Gradient Investments »

Oruka Therapeutics shares owned by Gradient Investments

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Gradient Investments from 13F filings

Historical chart of Gradient Investments investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Gradient Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Gradient Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $273k 2.9k 95.17

More positions owned by Gradient Investments

Spdr Series Trust St Str P500etf (SPYM)
NVIDIA Corporation (NVDA)
Doubleline Etf Trust Mortgage Etf (DMBS)
Apple (AAPL)
Amazon (AMZN)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Alphabet Cap Stk Cl C (GOOG)
Janus Detroit Str Tr Henderson Mtg (JMBS)
World Gold Tr Spdr Gld Minis (GLDM)
Aim Etf Products Trust Allianzim Us Equ (SEPU)
Microsoft Corporation (MSFT)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Columbia Etf Tr I Resh Enhnc Cor (RECS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Ishares U S Etf Tr U.s. Tech Indepd (IETC)

View all positions for Gradient Investments

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Paradigm Biocapital Advisors
Rtw Investments
Deep Track Capital
Vanguard Capital Management
State Street Corporation
Remedium Capital Partners
Perceptive Advisors
Polar Capital Holdings
Citadel Advisors
Franklin Resources

View all funds holding Oruka Therapeutics